These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33682475)
1. Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data. Simon ST; Mandair D; Tiwari P; Rosenberg MA J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):335-340. PubMed ID: 33682475 [TBL] [Abstract][Full Text] [Related]
2. Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis. Simon ST; Trinkley KE; Malone DC; Rosenberg MA J Med Internet Res; 2022 Dec; 24(12):e42163. PubMed ID: 36454608 [TBL] [Abstract][Full Text] [Related]
3. Machine Learning Techniques Outperform Conventional Statistical Methods in the Prediction of High Risk QTc Prolongation Related to a Drug-Drug Interaction. Van Laere S; Muylle KM; Dupont AG; Cornu P J Med Syst; 2022 Nov; 46(12):100. PubMed ID: 36418746 [TBL] [Abstract][Full Text] [Related]
4. Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data. Hincapie-Castillo JM; Staley B; Henriksen C; Saidi A; Lipori GP; Winterstein AG Am J Health Syst Pharm; 2019 Jul; 76(14):1059-1070. PubMed ID: 31185072 [TBL] [Abstract][Full Text] [Related]
5. Assessment of a Machine Learning Model Applied to Harmonized Electronic Health Record Data for the Prediction of Incident Atrial Fibrillation. Tiwari P; Colborn KL; Smith DE; Xing F; Ghosh D; Rosenberg MA JAMA Netw Open; 2020 Jan; 3(1):e1919396. PubMed ID: 31951272 [TBL] [Abstract][Full Text] [Related]
6. Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review. Tomaselli Muensterman E; Tisdale JE Pharmacotherapy; 2018 Aug; 38(8):813-821. PubMed ID: 29882591 [TBL] [Abstract][Full Text] [Related]
7. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval. Lorberbaum T; Sampson KJ; Woosley RL; Kass RS; Tatonetti NP Drug Saf; 2016 May; 39(5):433-41. PubMed ID: 26860921 [TBL] [Abstract][Full Text] [Related]
8. Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device. Giudicessi JR; Schram M; Bos JM; Galloway CD; Shreibati JB; Johnson PW; Carter RE; Disrud LW; Kleiman R; Attia ZI; Noseworthy PA; Friedman PA; Albert DE; Ackerman MJ Circulation; 2021 Mar; 143(13):1274-1286. PubMed ID: 33517677 [TBL] [Abstract][Full Text] [Related]
9. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs. Bindraban AN; Rolvink J; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML Int J Clin Pharm; 2018 Oct; 40(5):1372-1379. PubMed ID: 30051227 [TBL] [Abstract][Full Text] [Related]
11. Prediction of incident myocardial infarction using machine learning applied to harmonized electronic health record data. Mandair D; Tiwari P; Simon S; Colborn KL; Rosenberg MA BMC Med Inform Decis Mak; 2020 Oct; 20(1):252. PubMed ID: 33008368 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Tisdale JE; Jaynes HA; Kingery JR; Mourad NA; Trujillo TN; Overholser BR; Kovacs RJ Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):479-87. PubMed ID: 23716032 [TBL] [Abstract][Full Text] [Related]
13. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy. Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Ott CA; Walroth TA; Williams G; Moe PR; Wilbrandt M; Tisdale JE Pharmacotherapy; 2021 Jun; 41(6):494-500. PubMed ID: 33772822 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US. Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851 [TBL] [Abstract][Full Text] [Related]
15. Incidence and outcomes of long QTc in acute medical admissions. Mahmud R; Gray A; Nabeebaccus A; Whyte MB Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237 [TBL] [Abstract][Full Text] [Related]
16. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Mayet S; Gossop M; Lintzeris N; Markides V; Strang J Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918 [TBL] [Abstract][Full Text] [Related]
17. Impact of left ventricular hypertrophy on QT prolongation and associated mortality. Haugaa KH; Bos JM; Borkenhagen EJ; Tarrell RF; Morlan BW; Caraballo PJ; Ackerman MJ Heart Rhythm; 2014 Nov; 11(11):1957-65. PubMed ID: 24956189 [TBL] [Abstract][Full Text] [Related]
18. An explainable algorithm for detecting drug-induced QT-prolongation at risk of torsades de pointes (TdP) regardless of heart rate and T-wave morphology. Alahmadi A; Davies A; Royle J; Goodwin L; Cresswell K; Arain Z; Vigo M; Jay C Comput Biol Med; 2021 Apr; 131():104281. PubMed ID: 33636421 [TBL] [Abstract][Full Text] [Related]
19. Institution-wide QT alert system identifies patients with a high risk of mortality. Haugaa KH; Bos JM; Tarrell RF; Morlan BW; Caraballo PJ; Ackerman MJ Mayo Clin Proc; 2013 Apr; 88(4):315-25. PubMed ID: 23541006 [TBL] [Abstract][Full Text] [Related]
20. Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation. Lorberbaum T; Sampson KJ; Chang JB; Iyer V; Woosley RL; Kass RS; Tatonetti NP J Am Coll Cardiol; 2016 Oct; 68(16):1756-1764. PubMed ID: 27737742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]